The Price for Drugs To Be Transparent
To clarify the issue of pricing for drugs, to avoid price variations for the same drug in different regions, the Government of the RF is improving legislation in the sphere of public purchase and purchases by publicly owned companies.
Igor Shuvalov, First Vice-Prime Minister spoke on that issue at a meeting of extended board of the Federal Antimonopoly Service (FAS). He told, that currently a scheme is being developed concurrently with modernization of electronic sites and the principle of purchase for public and municipal needs, and a specific drug pricing component. The idea is to make the public segment absolutely transparent.
He expressed hope that it will be possible to persuade the parliament to accept amendments to the law on public purchase and law on purchase by publicly owned companies by the end of the year, thus improving the competitiveness at electronic tenders.